Allopregnanolone concentrations and premenstrual syndrome.
about
Progesterone for premenstrual syndromeProgesterone for premenstrual syndromeMedroxyprogesterone acetate antagonizes the effects of estrogen treatment on social and sexual behavior in female macaques.The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatmentNeurosteroids: endogenous role in the human brain and therapeutic potentialsEndogenous and synthetic neurosteroids in treatment of Niemann-Pick Type C diseaseNeurosteroids in the context of stress: implications for depressive disordersReproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?The role of ovarian hormone-derived neurosteroids on the regulation of GABAA receptors in affective disordersAllopregnanolone as a mediator of affective switching in reproductive mood disordersSex differences in anxiety and emotional behavior.Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction.Tolerance to allopregnanolone with focus on the GABA-A receptor.Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder.Sleep, Hormones, and Circadian Rhythms throughout the Menstrual Cycle in Healthy Women and Women with Premenstrual Dysphoric Disorder.Mental and Reproductive Health Correlates of Academic Performance among Debre Berhan University Female Students, Ethiopia: The Case of Premenstrual Dysphoric DisorderSteroid withdrawal in the mouse results in anxiogenic effects of 3alpha,5beta-THP: a possible model of premenstrual dysphoric disorder.Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?Divergent neuroactive steroid responses to stress and ethanol in rat and mouse strains: relevance for human studies.Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments.Hypothalamic-pituitary-adrenal axis modulation of GABAergic neuroactive steroids influences ethanol sensitivity and drinking behaviorEffects and Mechanisms of 3α,5α,-THP on Emotion, Motivation, and Reward Functions Involving Pregnane Xenobiotic Receptor.Disadaptive disorders in women: allopregnanolone, a sensitive steroid.5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric DisorderAnger Emotional Stress Influences VEGF/VEGFR2 and Its Induced PI3K/AKT/mTOR Signaling Pathway.Mass spectrometric assay and physiological-pharmacological activity of androgenic neurosteroidsAnxiety Sensitivity as a Moderator of the Association Between Premenstrual Symptoms and Posttraumatic Stress Disorder Symptom Severity.Stereospecific reduction of 5β-reduced steroids by human ketosteroid reductases of the AKR (aldo-keto reductase) superfamily: role of AKR1C1-AKR1C4 in the metabolism of testosterone and progesterone via the 5β-reductase pathwayBiopsychosocial aspects of premenstrual syndrome and premenstrual dysphoric disorder.Advances in neurosteroids: role in clinical practice.Neurosteroids in clinical practice: implications for women's health.Reproductive Steroid Regulation of Mood and Behavior.Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study.The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback.Cellular distribution of the GABAA receptor-modulating 3alpha-hydroxy, 5alpha-reduced pregnane steroids in the adult rat brain.Evaluation of the effect of acute sibutramine in female rats in the elevated T-maze and elevated plus-maze tests.Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS.Pattern and correlates of premenstrual symptomatology amongst Nigerian University students.Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome.Gonadotropin-releasing hormone-stimulated gonadotropin levels in women with premenstrual dysphoria.
P2860
Q24201337-6B113B04-A71E-4BF2-A010-9105FE65F57CQ24241153-FDECF7D0-32F8-4742-82C7-FA730FAFAB1FQ24542881-027537F5-5392-4DAD-8659-F033A1992CD5Q24561815-ECE59833-88C7-4137-9388-6EB8946C2105Q24632113-5A2E459E-1824-468C-9896-4532962D257FQ24644950-2D5395E5-E37A-4151-8357-79904CB67ABCQ24646222-89A59CEE-9077-49D2-B097-BAC4EB4CC32AQ24650090-D88FEAD8-02AB-46FC-9A7B-BF7A1F7A4D7FQ26851296-A87130FA-9B25-43CF-92BE-450E43793BE5Q26866177-17B0E4A0-0B51-495B-955F-B428E956D6FBQ30439276-517C8FB8-8524-4D38-91F5-760EF31F1A13Q30461432-26559B9E-A9D1-48DE-8734-B45BD60BDF17Q30471700-07EE425E-641E-45A8-B053-42BCBBE15B2CQ30488137-7EADCD97-976C-4A01-81F8-12E186064FB4Q33633378-D9E73035-ED2F-4232-8C83-B235B04BCEC6Q33786750-934ED130-CAC2-415B-83D3-214431F518A3Q33919767-979C31A2-077B-4E95-89C6-9FB91DB7B394Q34054017-EF68E11D-0EED-4CF3-AE64-5EEA13E5F2F3Q34054035-6558B620-94E8-498F-ACFE-939125B6AB12Q34622392-5B7FFA09-69C4-4563-BB7D-DE9B72DD8465Q35236873-99978D7F-6DDC-4DDF-8C29-B73A0166EF31Q35681226-7489EAFA-4003-4C9A-A2EA-DD3E827833A3Q36051183-E0B9843F-1203-4C39-8E48-895C88450A2BQ36565664-AEECA5D9-967C-4794-BFB9-15F01078CC6FQ36626309-0E69C01C-EB83-4B94-9887-02DAEFAFFB25Q36666477-6167FD74-140A-44CB-8B63-FEFD20612E23Q36669417-FD23352C-0EE0-4619-840B-4CB587759980Q37302647-38C3EECC-9858-4F56-AE20-1EE8823431ABQ38027189-D736D421-18D3-430C-976D-3807728C7184Q38121153-A36B209F-7FB8-453A-B7CC-35076BBFA56FQ38471653-EBB0C83A-5952-439A-AD20-55473AB5DA90Q38878217-CF7F0542-B5F5-41CF-ABB2-1B76DC967667Q39934162-B8B6F115-1F56-43D3-9C23-E5609EA731BBQ41687556-0C6AED72-7AAF-4E9D-84E0-20325D376FC4Q42168657-1A336A9D-56A6-45B4-BA0A-933730CD4B02Q42618077-3A287C13-1FC9-4B06-AC7C-8D5376004B03Q42972731-6CA22E21-DC60-4EAF-8AC3-FE47B0D1BF80Q44068061-2AE21028-BBA4-4F29-BB38-F679A6FE7753Q44935076-CE072487-B081-49FE-B9E5-6FD962BAA1F2Q45277776-29E70847-4270-491E-BB52-6E2B8CE248B0
P2860
Allopregnanolone concentrations and premenstrual syndrome.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Allopregnanolone concentrations and premenstrual syndrome.
@en
Allopregnanolone concentrations and premenstrual syndrome.
@nl
type
label
Allopregnanolone concentrations and premenstrual syndrome.
@en
Allopregnanolone concentrations and premenstrual syndrome.
@nl
prefLabel
Allopregnanolone concentrations and premenstrual syndrome.
@en
Allopregnanolone concentrations and premenstrual syndrome.
@nl
P2093
P356
P1476
Allopregnanolone concentrations and premenstrual syndrome.
@en
P2093
A D Genazzani
A R Genazzani
F Bernardi
F Petraglia
P Monteleone
P304
P356
10.1530/EJE.0.1420269
P577
2000-03-01T00:00:00Z